At a glance
- Originator Aventis
- Class Small molecules
- Mechanism of Action Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Arrhythmias; Atrial fibrillation
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Arrhythmias in Germany (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Atrial-fibrillation in Germany (PO)
- 15 Aug 2006 A preclinical study has been added to the Arrhythmias pharmacodynamics section